Home > News Shots > World

By Vinershea | Aug 17, 2020 04:39 PM

With countries racing to come up with a COVID-19 vaccine, US drug developer Novavax Inc confirmed that it is starting a mid-stage study of its experimental COVID-19 vaccine in South Africa. 

novavax begins mid stage study of covid19 vaccine in south africa

This confirmation of the vaccine comes at a time when the country is experiencing a surge in coronavirus cases.

The company in a statement said that the Phase 2b trial study of NVX-CoV2373 will be conducted on about 2,665 healthy adults and will evaluate the safety and immunogenicity in about 240 medically stable and HIV-positive adults. 

Meanwhile, Novavax research chief Gregory Glenn claimed that, "Because South Africa is experiencing a winter surge of COVID-19 disease, this important Phase 2b clinical trial has the potential to provide an early indication of efficacy, along with additional safety and immunogenicity data for NVX-CoV2373."

With the current rise of COVID-19 cases, South Africa is fifth-worst affected country. Till date it had 5,83,653 coronavirus cases and 11,677 deaths. 

Further in its statement, the company stated that the Bill & Melinda Gates Foundation is providing a $15 million grant towards the clinical trial. Further giving clarity on its Phase 2 trial, Novavax said it intends to initiate the Phase 2 portion of this trial in the United States and Australia and that it would include about 1,500 candidates.

However in July, the US government had awarded Novavax $1.6 billion to cover testing and manufacturing of a potential vaccine for the novel coronavirus in the United States which aimed to deliver a 100 million doses by January.

Check the press release here:

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. Novavax begins mid stage study of covid19 vaccine in south africa | World News.